Novo Nordisk A S annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Novo Nordisk A S Operating Expenses Growth & History (NVO)
Novo Nordisk A S's operating expenses was kr122.62B for fiscal 2025.
View full Novo Nordisk A S company overviewNovo Nordisk A S annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | kr122.62B | kr5.08B | +4.32% |
| 2024 | 2024-12-31 | kr117.54B | kr23.62B | +25.15% |
| 2023 | 2023-12-31 | kr93.92B | kr20.23B | +27.44% |
| 2022 | 2022-12-31 | kr73.70B | kr15.20B | +25.98% |
| 2021 | 2021-12-31 | kr58.50B | kr6.61B | +12.74% |
| 2020 | 2020-12-31 | kr51.89B | kr2.44B | +4.93% |
| 2019 | 2019-12-31 | kr49.45B | — | — |
Novo Nordisk A S quarterly operating expenses
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | kr34.33B | kr3.77B | +12.32% |
| Q1 2026 | 2026-03-31 | kr23.61B | −kr2.80B | −10.60% |
| Q4 2025 | 2025-12-31 | kr32.26B | −kr3.66B | −10.19% |
| Q3 2025 | 2025-09-30 | kr33.39B | kr7.21B | +27.54% |
| Q2 2025 | 2025-06-30 | kr30.56B | −kr1.29B | −4.05% |
| Q1 2025 | 2025-03-31 | kr26.41B | kr2.82B | +11.95% |
| Q4 2024 | 2024-12-31 | kr35.92B | — | — |
| Q3 2024 | 2024-09-30 | kr26.18B | — | — |
| Q2 2024 | 2024-06-30 | kr31.85B | — | — |
| Q1 2024 | 2024-03-31 | kr23.59B | — | — |
Novo Nordisk A S operating expenses trends
Over the last five fiscal years, Novo Nordisk A S's operating expenses increased from kr51.89B to kr122.62B, a change of kr70.73B. The latest reported quarter, Q2 2026, shows kr34.33B.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novo Nordisk A S source filings ↗Community posts
Novo Nordisk reports positive STEP Young results in children aged 6 to under 12
Novo Nordisk announced first STEP Young Phase 3 results on 7 September 2026. Trial design and outcome The randomised, double-blind study involved 165 children aged 6 to under 12, comparing weekly semaglutide with placebo. Both groups receiv ...